Back to top Open menu arrow
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

  1. Department of Psychiatry, Asan Medical Center, Songpa-gu, Seoul, Republic of Korea
  2. Jongno-gu, Seoul, Republic of Korea
  3. Center for Hospital Medicine, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
  4. Corresponding Author: Seok-Jin Choi, MD, Department of Neurology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea ([email protected]).
  5. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Republic of Korea
  6. Jongno-gu, Seoul, Republic of Korea
  7. Department of Neurology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Dongjak-gu, Seoul, Republic of Korea
  8. Jongno-gu, Seoul, Republic of Korea
  1. Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162–172. PubMed CrossRef
  2. Ng AS, Rademakers R, Miller BL. Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci. 2015;1338(1):71–93. PubMed CrossRef
  3. Lillo P, Savage S, Mioshi E, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler. 2012;13(1):102–109. PubMed CrossRef
  4. Lou JS, Reeves A, Benice T, et al. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60(1):122–123. PubMed CrossRef
  5. Averill AJ, Kasarskis EJ, Segerstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8(4):243–254. PubMed CrossRef
  6. Kurt A, Nijboer F, Matuz T, et al. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs. 2007;21(4):279–291. PubMed CrossRef
  7. Van Heeringen K, Hawton K, Williams JMG. Pathways to suicide: an integrative approach. In: Hawton K, Van Heeringen K, eds. The International Handbook of Suicide and Attempted Suicide. John Wiley & Sons; 2000:223-234.
  8. Druss RG. The Psychology of Illness: in Sickness and in Health. American Psychiatric Publishing; 1995.
  9. Chochinov HM, Wilson KG, Enns M, et al. Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics. 1998;39(4):366–370. PubMed CrossRef
  10. Ribeiro JD, Huang X, Fox KR, et al. Depression and hopelessness as risk factors for suicide ideation, attempts and death: meta-analysis of longitudinal studies. Br J Psychiatry. 2018;212(5):279–286. PubMed CrossRef
  11. Reeve J, Lloyd-Williams M, Dowrick C. Depression in terminal illness: the need for primary care-specific research. Fam Pract. 2007;24(3):263–268. PubMed CrossRef
  12. Nock MK, Borges G, Bromet EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192(2):98–105. PubMed CrossRef
  13. Silva-Moraes MH, Bispo-Torres AC, Barouh JL, et al. Suicidal behavior in individuals with amyotrophic lateral sclerosis: a systematic review. J Affect Disord. 2020;277:688–696. PubMed CrossRef
  14. National Law Information Center. Enforcement Decree of the National Health Insurance Act. Korean Law Information Center website. https://www.law.go.kr/LSW/eng/engLsSc.do?menuId=2&section=lawNm&query=%EA%B5%AD%EB%AF%BC%EA%B1%B4%EA%B0%95%EB%B3%B4%ED%97%98%EB%B2%95&x=0&y=0#liBgcolor0. Accessed February 19, 2021.
  15. Centers for Disease Control and Prevention. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). ICD.WHO.INT website. https://icd.who.int/browse10/2019/en. Accessed February 19, 2021.
  16. Gasse C, Danielsen AA, Pedersen MG, et al. Positive predictive value of a register-based algorithm using the Danish National Registries to identify suicidal events. Pharmacoepidemiol Drug Saf. 2018;27(10):1131–1138. PubMed CrossRef
  17. Park S, Rim SJ, Jo M, et al. Comorbidity of alcohol use and other psychiatric disorders and suicide mortality: data from the South Korean National Health Insurance cohort, 2002 to 2013. Alcohol Clin Exp Res. 2019;43(5):842–849. PubMed CrossRef
  18. Chen P-Y, Liu S-K, Chen C-L, et al. Long-term statin use and dementia risk in Taiwan. J Geriatr Psychiatry Neurol. 2014;27(3):165–171. PubMed CrossRef
  19. Chu CY, Cho YT, Jiang JH, et al. Patients with chronic urticaria have a higher risk of psychiatric disorders: a population-based study. Br J Dermatol. 2020;182(2):335–341. PubMed CrossRef
  20. Cunningham R, Sarfati D, Peterson D, et al. Premature mortality in adults using New Zealand psychiatric services. N Z Med J. 2014;127(1394):31–41. PubMed
  21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509. CrossRef
  22. Borges G, Nock MK, Haro Abad JM, et al. Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry. 2010;71(12):1617–1628. PubMed CrossRef
  23. Piscopo K, Lipari R, Cooney J, et al. Suicidal thoughts and behavior among adults: results from the 2015 National Survey on Drug Use and Health. SAMHSA website. https://www.samhsa.gov/data/sites/default/files/NSDUH-DR-FFR3-2015/NSDUH-DR-FFR3-2015.pdf. Accessed February 19, 2021.
  24. Lee S-U, Park J-I, Lee S, et al. Changing trends in suicide rates in South Korea from 1993 to 2016: a descriptive study. BMJ Open. 2018;8(9):e023144. PubMed CrossRef
  25. Sun FK, Long A, Huang XY, et al. A grounded theory study of action/interaction strategies used when Taiwanese families provide care for formerly suicidal patients. Public Health Nurs. 2009;26(6):543–552. PubMed CrossRef
  26. Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System. CDC website. https://webappa.cdc.gov/sasweb/ncipc/nfirates.html. Accessed February 19, 2021.
  27. Hawton K. Restricting access to methods of suicide: rationale and evaluation of this approach to suicide prevention. Crisis. 2007;28(S1):4–9. CrossRef
  28. Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ. 2001;322(7296):1203–1207. PubMed CrossRef
  29. Turvill J, Burroughs A, Moore K. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet. 2000;355(9220):2048–2049. CrossRef
  30. Beautrais AL. Suicides and serious suicide attempts: two populations or one? Psychol Med. 2001;31(5):837–845. PubMed CrossRef
  31. Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry. 2005;62(4):427–432. PubMed CrossRef
  32. Brown GK, Beck AT, Steer RA, et al. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol. 2000;68(3):371–377. PubMed CrossRef
  33. Nock MK, Borges G, Bromet EJ, et al. Suicide and suicidal behavior. Epidemiol Rev. 2008;30(1):133–154. PubMed CrossRef
  34. Thomson L, Sheehan KA, Meaney C, et al. Prospective study of psychiatric illness as a predictor of weight loss and health related quality of life one year after bariatric surgery. J Psychosom Res. 2016;86:7–12. PubMed CrossRef
  35. Dawood S, Poole N, Fung R, et al. Neurologists’ detection and recognition of mental disorder in a tertiary in-patient neurological unit. BJPsych Bull. 2018;42(1):19–23. PubMed CrossRef
  36. Juul D, Gutmann L, Adams HP Jr, et al. Training in neurology: feedback from graduates about the psychiatry component of residency training. Neurology. 2021;96(5):233–236. PubMed
  37. Eliasen A, Dalhoff KP, Horwitz H. Neurological diseases and risk of suicide attempt: a case-control study. J Neurol. 2018;265(6):1303–1309. PubMed CrossRef
  38. Fang F, Valdimarsdóttir U, Fürst CJ, et al. Suicide among patients with amyotrophic lateral sclerosis. Brain. 2008;131(Pt 10):2729–2733. PubMed CrossRef
  39. Tsai C-P, Chang B-H, Lee CT-C. Underlying cause and place of death among patients with amyotrophic lateral sclerosis in Taiwan: a population-based study, 2003–2008. J Epidemiol. 2013;23(6):424–428. PubMed CrossRef
  40. Bensimon G, Lacomblez L, Meininger V; ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330(9):585–591. PubMed CrossRef
  41. Writing Group; Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16(7):505–512. PubMed CrossRef
  42. Stavroulakis T, Baird WO, Baxter SK, et al. Factors influencing decision-making in relation to timing of gastrostomy insertion in patients with motor neurone disease. BMJ Support Palliat Care. 2014;4(1):57–63. PubMed CrossRef
  43. Bae JS, Hong YH, Baek W, et al; Korean ALS/MND Research Group. Current status of the diagnosis and management of amyotrophic lateral sclerosis in Korea: a multi-center cross-sectional study. J Clin Neurol. 2012;8(4):293–300. PubMed CrossRef
  44. Fang T, Al Khleifat A, Stahl DR, et al; Uk-Mnd LicalS. Comparison of the King’s and MiToS staging systems for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3–4):227–232. PubMed CrossRef

Save Save

Share Share

Cite Cite

Read the Current Issue

Vol 85, 2024 3

Can Our Collective Experiences As Clinicians Improve Mental Health Care?

SSRI Discontinuation and AUD Relapse

Reproductive Pharmacovigilance and Best Practices

Olanzapine and Mirtazapine for Cancer-Related Anorexia

Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia

Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
View current Issue

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe